Skip to content
TrialMatch
Sign up
Recruiting

Acupressure for Cough in Lung Cancer Survivors

Create a profile to match View the full record on ClinicalTrials.gov

About this study

The goal of this randomized controlled trial is to examine the effect of an acupressure intervention in alleviating cough and reducing co-occurring symptoms (dyspnea, cough, and fatigue) in patients with lung cancer. The hypotheses are: 1. Acupressure can alleviate cough in lung cancer survivors; 2. Acupressure can reduce a cough-related symptom cluster (dyspnea-cough-fatigue) experienced by lung cancer survivors; 3. Acupressure can reduce the symptom burden and improve the health-related quality of life and functional capacity of lung cancer survivors experiencing cough. Participants will: Receive acupressure for 8 weeks or receive an education booklet; Keep a diary of their acupressure practice and symptoms; Be assessed at baseline (T0), early intervention (T1), post-intervention (T2), and 8 weeks after the intervention period (T3).

Condition
Lung Cancer (Diagnosis), Acupressure, Coughing, Symptom Cluster
Tested
acupressure, Education
Sponsor
The University of Hong Kong

Who can join

Age
18 years and older
Sex
All sexes
Healthy volunteers
Not accepted

Inclusion 8

  • Minimum age: 18 years
  • Study condition: Lung Cancer (Diagnosis), Acupressure, Coughing, Symptom Cluster
  • be at least 18 years of age;
  • have a diagnosis of LC at any stage and of any pathological type;
  • have a cough symptom rating ≥3 on a 0 to 10 numeric rating scale within 7 days preceding enrollment;
  • can perform acupressure independently in daily activities;
  • be able to read Chinese and communicate in Cantonese or Mandarin;
  • be able to provide informed consent.

Exclusion 5

  • have unstable chronic diseases other than LC;
  • have received acupressure or acupuncture within the three months preceding study enrollment;
  • have serious illnesses or other conditions that prevent the participants from following the intervention protocols;
  • have a life expectancy of less than 3 months;
  • Be currently participating in other research programs that may affect the outcomes under investigation.

Where

2 sites, 2 recruiting

University of Hong Kong-Shenzhen Hospital

Shenzhen, Guangdong, China

Recruiting

Queen Mary Hospital

Hong Kong, Hong Kong

Recruiting

Contact

Potential match only. Final eligibility is determined by the study team.